1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution
Bioquell, Inc. Logo

Hydrogen Peroxide Vapor technology is hot topic at infectious disease conference.

Hydrogen peroxide bio-decontamination technology is one of the hot topics at this year’s 49th Annual Meeting of the Infectious Diseases Society of America and the HIV Medicine Association in Boston, Massachusetts on October 20-23, 2011.

 
PRLog - Oct. 20, 2011 - Hydrogen peroxide bio-decontamination technology is one of the hot topics at this year’s 49th Annual Meeting of the Infectious Diseases Society of America and the HIV Medicine Association. Three scientific abstracts are being presented on hydrogen peroxide vapor (HPV) at the meeting in Boston, Massachusetts on October 20-23, 2011.

Commenting on this latest research, James Salkeld, Head of Healthcare at Bioquell said, “Hydrogen peroxide vapor technology continues to have a strong profile among infection control professionals at all levels. Its efficacy at dealing with key healthcare associated infections (HAIs) such as Clostridium difficile and Acinetobacter is becoming better known, providing a rapid solution to help in bringing outbreaks under control and reducing endemic infection.”
   
The abstracts include reports of reducing endemic cases of Clostridium difficile and controlling outbreaks of Acinetobacter baumannii and NDM-1-producing Klebsiella pneumoniae.

Performed at the Wellstar group of hospitals in Atlanta, GA, the first study illustrates a system-wide reduction in the incidence of C. difficile, VRE and MRSA following the introduction of a bundle of prevention and control measures including Bioquell’s HPV proactive service (onsite equipment and bio-decontamination specialists). Here C. difficile rates fell by 36%, VRE by 68% and MRSA by 11%.

Management of a multi-year outbreak of Acinetobacter baumannii in an ICU setting was highlighted in the second study at Albany, NY. With the introduction of Bioquell HPV technology in 2010, rates dropped by 80% against baseline and 95% compared to the peak of the outbreak. Prior to the HPV technology, standard infection control methods had failed to bring the outbreaks under control. Whilst the introduction of surveillance cultures made some impact, implementation of HPV technology solved the problem.

The third study was conducted at a Howard County Hospital, affiliated with Johns Hopkins, MD. Although NDM-1-producing Klebsiella pneumoniae was not found in the environment during the study, the team decided to use Bioquell HPV technology to disinfect the patient care area. Such treatment is vital when dealing with some of the hard to treat Gram-negatives.

The three abstracts are titled:

•   A System-Wide Reduction in the Incidence of C. difficile and MDROs due to an Infection Prevention & Control Bundle
•   Management of a multi-year MDR Acinetobacter baumannii outbreak in the ICU setting
•   Management of a New Delhi Metallo-beta-lactamase-1 enzyme (NDM-1)-Producing Klebsiella pneumoniae : Infection Control and Medical Implications

# # #

Bioquell specializes in the design, manufacture and application of complete bio-decontamination solutions for airborne and surface contamination in the healthcare, life sciences, food production and defense sectors. Bioquell's unique hydrogen peroxide vapor (HPV) bio-decontamination technology is used across the globe to eradicate problematic bacteria, viruses and fungi, throughout a wide range of applications. Deployment of Bioquell's HPV process provides residue-free, safe and repeatable sterilization of rooms, buildings, equipment and sensitive electronics. It is a clear alternative when replacing traditional decontaminants such as formaldehyde or chlorine-based products.

Bioquell also provides custom chemical, biological, radioactive and nuclear (CBRN) filtration equipment for different applications in the defense industry. This equipment is complemented by integral air conditioning systems and auxiliary power units. For more information, please visit http://www.bioquellus.com.

--- End ---

Click to Share

Contact Email:
***@bioquell.com Email Verified
Source:Bioquell, Inc.
Phone:+1.215.682.0225
Zip:19044
City/Town:Horsham - Pennsylvania - United States
Industry:Health, Biotech, Science
Tags:hydrogen peroxide vapor, infectious disease control, hospital associated infections, hai, hpv, mrsa
Shortcut:prlog.org/11702090
Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “

More...

Trending News...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
9K2K1K
Click to Share